Bank of Montreal Can trimmed its stake in iShares MBS ETF (NASDAQ:MBB – Free Report) by 59.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,012,219 shares of the company’s stock after selling 1,481,900 shares during the period. Bank of Montreal Can owned 0.29% of iShares MBS ETF worth $93,671,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of the stock. Financial Management Professionals Inc. bought a new stake in shares of iShares MBS ETF during the first quarter valued at approximately $26,000. Chris Bulman Inc purchased a new position in iShares MBS ETF during the 2nd quarter valued at about $31,000. Versant Capital Management Inc bought a new stake in iShares MBS ETF during the first quarter worth about $32,000. Rothschild Investment LLC purchased a new stake in iShares MBS ETF in the second quarter worth about $33,000. Finally, PSI Advisors LLC increased its stake in shares of iShares MBS ETF by 2,289.5% during the second quarter. PSI Advisors LLC now owns 454 shares of the company’s stock valued at $42,000 after purchasing an additional 435 shares in the last quarter. Institutional investors own 91.70% of the company’s stock.
iShares MBS ETF Price Performance
Shares of MBB opened at $96.25 on Wednesday. The business’s 50 day moving average price is $94.92 and its 200-day moving average price is $92.66. iShares MBS ETF has a 52 week low of $85.28 and a 52 week high of $96.76.
iShares MBS ETF Dividend Announcement
About iShares MBS ETF
iShares MBS ETF (the Fund), formerly iShares Barclays MBS Bond Fund, is an exchange-traded fund (ETF). The Fund seeks investment results, which correspond to the price and yield performance of the Barclays Capital U.S. MBS Index (the Index). The Index measures the performance of investment grade mortgage-backed pass-through securities issued by the Government National Mortgage (GNMA).
Further Reading
- Five stocks we like better than iShares MBS ETF
- The 3 Best Blue-Chip Stocks to Buy Now
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is a buyback in stocks? A comprehensive guide for investors
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Invest in the FAANG Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for iShares MBS ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MBS ETF and related companies with MarketBeat.com's FREE daily email newsletter.